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a strong role in the identification of high risk patients, their 
clinical management, and prognosis. The reorganization of 
the medical system has been associated with the develop-
ment of new instruments for clinical assessment, focused 
on clinical and socio-economic issues, resulting in a multidi-
mensional geriatric assessment.
A large number of approaches have been validated in dif-
ferent clinical settings and populations, until the develop-
ment of multidimensional instruments was proven to play a 
crucial role in the identification of frail individuals and their 
clinical management. Interestingly, some of them, such as 
the Multidimensional Prognostic Index (MPI), proved to play 
a relevant role in mortality risk stratification even in specific 
clinical settings, such as chronic kidney disease. 
During the 20th century the demographic revolution of indus-
trialized countries, resulted in an increased life expectancy, 
achieving a mean-life up to 78 years for men and 84 years 
for women. The demographic changes lead to a higher inci-
dence of chronic conditions, multiple pathologies, and dis-
abilities with elevated risk of rapid deterioration in health and 
functional status requiring long-term care needs. 
In the past 50 years, chronic disease replaced acute dis-
ease as the dominant health problem. Nowadays, chronic 
diseases are the principal cause of disability and use of 
health services, consuming 80% of health expenditure. 
Chronic disease dramatically transformed the role of the 
caregiver, no less than the role of the patient and its family, 
turning medical intervention from a predominantly clinical 
to a multidisciplinary approach (1).
Indeed, advanced age is characterized by a higher preva-
lence of comorbidities, since the frequency of chronic 
conditions is age-related (2). Consequently, it is difficult to 
diagnose and categorize each pathology, which often do not 
present in a typical manner as they are atypical responses to 
very common illnesses.
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IntroductIon
During the last century the considerable increase in life ex-
pectancy has led to important demographic changes and, 
consequently, to new clinical scenarios. Nowadays, chronic 
conditions, comorbidities, and socio-economic factors con-
stitute a relevant issue for health management. In particular, 
the definition of frail elderly individuals has proven to play 
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Comorbidity is defined by the concurrent presence of two or 
more medically diagnosed diseases in the same individual, 
but both the coexistence of multiple pathologies in the same 
organ (the so called target-organ comorbidity), and the pres-
ence of different pathologies involving different organs and 
apparatus in the same patient (multi organ comorbidity) can 
be observed. 
The high prevalence of comorbidities in elderly patients is 
associated with functional impairment resulting in different 
levels of disability induced by the gradual loss of physiologic 
reserve (vulnerability) especially present in octogenarians: in 
this regard, the contribution of evident clinical comorbidity 
(active comorbidity) when compared to clinically silent co-
morbidity (passive comorbidity) is prevalent.
the frAIl elderly
In 1974 the ‘Federal Council on The Aging’ introduced the 
term ‘frail elderly’ to describe people with a high level of dis-
ability and critical socio-economic conditions (3). So far, the 
term ‘frail’ was occasionally used in scientific literature (4, 5), 
and, in the eighties, Woodhouse, Buchner and Brocklehurst 
(6-8) provided a more exhaustive and complete definition. In 
clinical practice, disabled elderly people are often reported 
interchangeably as dependent, comorbid, or frail. All these 
terms describe the most physically vulnerable subset of the 
elderly population needing enhanced care.
Consequently, the clinical practice of the 20th century had 
to deal with different typology of patients, where the close 
interrelationships between frailty, comorbidity, and disability 
had to be contextualized in the socio-economic setting of 
each patient. Moreover, comorbidity often means polyphar-
macy which in turn is responsible for more adverse effects 
and iatrogenic damage.
Intuitively, the main issue is to identify those high risk pa-
tients who present increased vulnerability to stressors, de-
creased physiologic reserves and multi-system dysregu-
lation, limited capacity to maintain homeostasis and to 
respond to internal and external stresses. Frailty, disability, 
and comorbidity are interrelated, since frailty and comorbid-
ity predict subsequent disability; disability may lead to frailty 
and worsen comorbidity, and frailty could contribute to the 
progression of chronic diseases (Fig. 1).
The Health and Social System therefore had to provide ad-
equate responses to the demographic changes, aiming to 
achieve continuous assistance in the services offered to el-
derly people based on a functional integration between local 
health units, hospital structures, and social services. 
The reorganization of the medical system was based on 
both therapeutic and rehabilitative issues in order to opti-
mize medical offer and economical expenses. To implement 
such a policy, an appropriate network of local services, 
managed by adequately trained and specialized profession-
als, was created. 
As regards the complexity of the medical approach, it was 
evident that traditional clinical assessment needed to be in-
tegrated with a comprehensive geriatric assessment. Con-
sequently, after the clinical validation by the ‘Crichton Royal 
Behavioural Rating Scale’ (9), Fried et al (10) suggested a 
definition of the term ‘frail’ based on prespecified clinical 
parameters, and subsequently identified a schematic ap-
proach to define the ‘frailty phenotype’ (11). 
MultIdIMensIonAl InstruMents
Since then, researchers identified different multidimensional 
instruments to identify frailty considering the complexity of 
the geriatric patient, especially cognitive ability, body func-
tion, general mood, and social and economic conditions.
The ‘first generation’ instruments had specific targets, and 
was applied to specific elderly populations. In particular, 
they aimed to identify and stratify the risk in predetermined 
clinical settings, such as patients with depression, cognitive 
impairment, physical disability, etc. 
Fig. 1 - Characteristics and prevalence of frailty in the elderly 
population.
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Functional ability was determined looking at activities of 
daily living (ADL) and instrumental activities of daily living 
(IADL). ADL are self-care activities a person performs daily, 
while IADL are activities needed to live independently. Two 
indices have been prepared for an objective assessment of 
functional ability: the Katz index (12) for ADL and the Lawton 
index (13) for IADL.
As regards depression, cognition, and mental health, sev-
eral instruments have been developed, such as the Geriatric 
Depression Scale (14), the Mini-Mental State Examination 
(15), etc. 
Subsequently, new multidimensional instruments have been 
introduced, creating global scores including several items 
that permitted exploring several different aspects of different 
pathologies and reassuming them in a single, standardized, 
and simple score, such as the Functional Independence 
Measure (FIM), Canadian Study of Health and Aging (CSHA), 
Clinical Frailty Scale, CSHA Frailty Index, MPI; etc.
FIM was introduced in 1983 and represents one of the first 
and more diffused 2nd generation instruments. The main 
purpose was to create a generic measure that could be ad-
ministered by clinicians to assess patients in all age groups 
with a wide variety of diagnoses and to measure the pa-
tient’s progress and assess rehabilitation outcomes (16). 
FIM assesses physical and cognitive disability taking into 
account 18 items scored on the level of assistance required 
to perform activities of daily living. The motor subscale (13 
items) collects information involving self-care, sphincter 
control, transfer, and locomotion, while the cognitive sub-
scale (five items) focuses on communication and social cog-
nition. Each item is scored from one to seven, where one 
represents total dependence and seven indicates complete 
independence. FIM is the major source of functional status 
and has clinical and administrative repercussions.
On the one hand, a high score at the time of admission re-
veals an improper indication at hospitalization, while very 
low scores identify patients that still need in-patient inten-
sive care and are not yet susceptible to rehabilitation. On 
the other hand, an incremented FIM score at the time of 
discharge identifies successful rehabilitation. Moreover, the 
relationship between improvement in FIM score and days of 
hospitalization detects clinical efficiency (16).
Subsequently, Fried et al (10), in a study performed on 5317 
individuals from the Cardiovascular Health Study, identified 
the characteristics able to detect the frailty phenotype, that 
were then combined into the frailty phenotype index (PFI); in 
particular, they assembled a multidimensional assessment 
comprised of five simple items: slow walking speed, im-
paired grip strength, self-reports of declining activity levels, 
exhaustion, and unintended weight loss. People with three 
or more of these deficits were defined as frail and those with 
none were said to be robust, while the presence of only one 
or two of these deficits identified a “pre-frail” status. Frailty 
phenotype predicted adverse outcomes such as: falls, hos-
pitalizations, disability, and death. In the population of this 
study the prevalence of frailty was 7% and the overlap, in the 
presence of both frailty, comorbidity, and disability was just 
21.5%. Indeed, such an instrument could be adopted uni-
vocally in a preclinical setting, being untrustworthy in hos-
pitalized patients in whom the active pathology is strongly 
associated with prognosis.
In 1987, in USA, the Nursing Home Reform Act introduced 
the RAI-MDS (Resident Assessment Instrument Minimum 
Data Set) (17) a new multidimensional instrument ideated to 
guide admission to and residence in nursing homes. It was 
validated and became obligatory in 1991. The key role of 
RAI-MDS is to adequately plan the extra hospital assistance 
of elderly people. The same system, renamed VAOR, was 
then adopted in Europe where it was implemented with new 
items, selected based on clinical setting, resulting in a more 
complete and appropriate instrument.
Consequently, this third generation instrument turns out to 
be suitable for both intensive care units, rehabilitation units, 
and residential and nursing homes. The extreme adaptability 
of this instrument is given by the fact that it is comprised of 
a core of fixed items (almost 70%) and another part (almost 
30%) that varies in dependence of the clinical setting. There 
are many different types of VAOR, all of them containing a 
proportion of common items intended to facilitate commu-
nication across multiple health care settings.
After being extensively studied and validated by the inter-
national literature, nowadays VAOR is the more complete 
instrument, having a large number of applications including 
care planning, outcome measurement, and quality indicators. 
A different approach to identify frailty has been reported by 
Rockwood et al (18) who drew up a frailty index and as-
sessed this in a population of 2305 elderly patients in the 
Canadian Study of Health and Aging. The frailty index was 
comprised of seventy different items. It included the pres-
ence and severity of current diseases, ability in activities of 
daily living, and physical and neurologic signs from the clini-
cal examinations. Results were then combined in a scale, 
from one to seven, assigning the score of one to very fit 
individuals and the score of seven to severely frail subjects. 
The frailty scale turned out to be highly correlated with the 
frailty index; and each category increment of the scale sig-
nificantly increased the medium-term risk of death and entry 
into an institutional facility.
Searle et al (19) reported a standard procedure for con-
structing a frailty index. They selected 40 health deficits 
4 © 2012 Società Italiana di Nefrologia - ISSN 1121-8428  
Rengo et al: Multidimensional geriatric evaluation
fulfilling the following criteria: associated with health status, 
age-related, not too early saturation in the selected popula-
tion. Deficit scores were combined in an index from 0 to 40. 
This systematic procedure for creating a frailty index turned 
out to be reproducible and a good predictor of mortality.
Pilotto et al (20) introduced the MPI, a one-year mortality 
index from a comprehensive geriatric assessment, vali-
dated on hospitalized elderly patients. This index included 
clinical, cognitive, functional, nutritional, and social param-
eters for a total of 63 items. In particular, functional status is 
assessed by ADL and IADL indices; cognitive status by the 
‘short portable mental status questionnaire’ (21); comor-
bidity by the Cumulative Illness Rating Scale (CIRS) (22); 
Nutritional status by the Mini Nutritional Assessment (MNA) 
(23); the risk of developing pressure sores by the Exton-
Smith Scale (ESS) (24). Number of drugs and medication 
use, and social aspects are also defined by this index. 
Three grades of MPI were identified: low risk, 0.0–0.33; 
moderate risk, 0.34–0.66; and severe risk, 0.67–1.0. Higher 
MPI scores were significantly associated with older age, 
female sex, lower educational level, and higher mortality. 
Interestingly, there was agreement between the estimated 
and the observed mortality after both six months and one 
year of follow-up.
Interestingly, in a recent multicenter one year follow-up study 
(25) the predictive accuracy of four frailty instruments was 
compared in a large population of hospitalized patients and 
MPI demonstrated a significantly higher mortality predictive 
power than others both after a short and long follow-up. 
It is important to underline that frailty estimates, provided 
by all the instruments cited above, are not equivalent since 
the scales utilized are quite different. Moreover, two recent-
ly published reviews (26, 27), were not able to demonstrate 
the accuracy of any of these indices in predicting mortality; 
thus, further validations to assess their clinical usefulness 
are still required. 
Kulminsky et al (28) compared the predictive prognostic val-
ue of “phenotypic frailty index” (PFI) and “deficit index” (DI) 
based on 48 elderly deficits (signs, symptoms, impairments, 
diseases). These instruments enabled categorizing subjects 
as robust, pre-frail, and frail. The authors found that, with the 
use of PFI the risk of death was underestimated in 720 per-
sons, while using DI the mortality risk was underestimated in 
134 persons. The authors concluded that, especially among 
the most vulnerable part of the elderly, both approaches are 
very helpful for discrimination of the risk of mortality; both 
are frailty related even if DI has more power for discriminat-
ing frail individuals on the basis of their death susceptibility. 
Noteworthy, in most cases, there was no correspondence 
between robust, pre-frail, and frail categories. 
AssessMent of the older pAtIent In  
specIfIc clInIcAl settIngs. pAtIents  
wIth kIdney dIseAse
Noteworthy, the usefulness of all existing instruments for 
comprehensive geriatric assessment is independent of the 
target organ disease and associated comorbidities. However, 
these measures cannot be considered as substitutes for the 
traditional functional and anatomic assessment of single or-
gans or apparatus. In this regard, this issue is even more im-
portant in the presence of kidney disease in elders who show 
significant age-related structural and functional renal modi-
fications. In fact, a serum creatinine concentration of 1 mg/
dL reflects a glomerular filtration rate (GFR) of 120 mL/min in 
a 20-year-old person and 60 mL/min in an 80-year-old (29). 
Consequently, serum creatinine is an unreliable indicator of 
GFR in elderly people, particularly in those with alterations to 
body composition, including weight loss and sarcopenia (30).
An accurate estimation of GFR in the elderly can be achieved 
with the Modification of Diet in Renal Disease (MDRD) (31) 
and the Cockcroft-Gault equations (32).
Decreased GFR, vascular dysautonomia, altered tubular han-
dling of creatinine, reduction in sodium reabsorption and po-
tassium secretion, and diminished renal reserve are described 
as physiologic impairment of the renal system (33, 34). Further-
more, a decreased function of atrial natriuretic factor because 
of an age-related renal resistance has been reported (35). 
Thus, in the elderly population, GFR values lower than that 
reported in the adult group, not necessarily associated with 
the presence of those abnormalities commonly recognized 
in chronic renal failure, such as impaired proximal tubular 
function, altered urea serum levels, serum levels and frac-
tional excretion of magnesium, calcium, phosphorus, and 
abnormal normal urinalysis (36, 37), etc. 
The prevalence of chronic kidney disease in patients aged 
over 70 is elevated (38).
The functional and structural changes of the aging kidney can 
hinder the identification of subclinical disease and the progno-
sis stratification in patients with impaired renal function. More-
over, GFR, which is very relevant clinically, may fail in predicting 
the mortality risk (39). In fact, the prognosis of elderly people 
with chronic kidney disease is related to functional and cogni-
tive issues, nutrition, etc (40). Furthermore, patients on chronic 
hemodialysis have a higher incidence of comorbidities, altered 
functional and metabolic status (41), abnormal body composi-
tion, frequently assume multi drug therapy, and are more sus-
ceptible to side effects (42). Consequently, multidimensional 
diagnostic tools have been developed in order to identity high 
risk old patients in the different clinical settings (43-45).
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A comprehensive geriatric assessment in patients with kid-
ney disease can integrate the clinical assessment and im-
prove its power in the prediction of prognosis. 
The usefulness of MPI in the prediction of mortality in older 
patients hospitalized for chronic kidney disease has been 
assessed in a population of 786 patients, with moderate to 
severe chronic kidney disease (46). In this study, accord-
ing to MPI scores, authors divided the population into three 
groups with low, moderate, and severe risk of mortality.
Higher MPI values were associated with higher mortality 
after one year. Interestingly, MPI revealed greater discrimi-
natory power than the common organ-specific prognostic 
indices; furthermore, MPI had a higher prognostic accuracy 
than GFR assessed by ROC curves.
The prognostic addictive value of MPI in patients with kid-
ney disease has been recently reconfirmed by Pilotto et al 
(47) in a study comparing the prognostic accuracy of MPI 
and GFR estimated by MDRD in which they concluded that 
adding MPI information to the eGFR markedly improve the 
prediction of two-year all-cause mortality.
These data underline the importance of a comprehensive 
geriatric assessment in the chronic kidney disease setting, 
suggesting that a multidimensional assessment, in addition 
to disease-specific parameters, is fundamental for accurate 
stratification of patients based on mortality risk.
Analogous findings have been reported in other specific 
clinical settings such as older patients with heart failure (48), 
pneumonia (49), gastrointestinal bleeding, and cirrhosis (50).
In conclusion, several data confirm that the integration of 
common clinical parameters with multidimensional geriatric 
instruments improves the management of older patients ei-
ther during the diagnostic and therapeutic phase, where the 
traditional clinical assessment is enlaced, in addition to the 
prognostic power of the clinical relevant indexes.
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